Nestlé

Nestlé Invests $200m More In Aimmune After Peanut Allergy Drug Approval

Nestlé Invests $200m More In Aimmune After Peanut Allergy Drug Approval

Aimmune Therapeutics Inc said on Wednesday the health science arm of Nestlé SA will invest an additional $200 million in the drugmaker, bringing the...

Investors Find Some Unilever Foods Hard To Swallow

Six months after Unilever's Alan Jope suggested he may get rid of brands without "purpose", investors are wondering when he will deliver. Thei...

Previous
Page 12
Next